drugset / Trial / NCT04400136

PPI Therapy Impact on GERD After Sleeve Gastrectomy

NCT04400136

Phase 0 Unknown 45 enrolled University of Roma La Sapienza
RandomizedCrossoverSingle-blindDiagnostic

Summary

The trial would to try to establish: * The best post-operative PPI prescription protocol after Sleeve Gastrectomy * The impact of PPI therapy on postoperative peptic diseases (erosive gastropathies, ulcers, duodenitis, esophagitis and/or Barrett) * The impact of PPI therapy on post-operative GERD symptoms (assessed with the use of two standard tests: MRGE-HRQL and GERDQ

Timeline

Start
2020-07-01
Primary completion
2021-07-01
Completion
2022-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 30 mg Oral